$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Principle of targeted therapy and mechanism of action of Momelotinib on myelofibrosis
2026-02-01 22:25:32
Check Details
What are the contraindications for Biken Pronol Tablets (Bituvi) and analysis of the precautions before use?
2026-02-01 22:25:32
Check Details
Which patients are best treated with decavatinib for psoriasis?
2026-02-01 22:25:32
Check Details
Does Apremilast (Otelor) cause gastrointestinal discomfort and how to deal with it
2026-02-01 22:25:32
Check Details
Analysis of the clinical application of Valganciclovir in preventing cytomegalovirus infection
2026-02-01 22:25:32
Check Details
Mecobalamin price range reference and cost comparison of different brands of drugs
2026-02-01 22:25:32
Check Details
Latest information on domestic marketing progress and approved indications of cobimetinib (cobimetinib)
2026-02-01 22:25:32
Check Details
How long does it take to effectively reduce pulmonary arterial hypertension after taking macitentan (Aopuxil)?
2026-02-01 22:25:32
Check Details
What is the difference between Tilidine and Tilorisen (Huacosi)? Why is it not recommended for some patients?
2026-02-01 22:25:32
Check Details
Comparison of the efficacy of Pretomanid and other anti-tuberculosis drugs and clinical analysis of combined drug regimens
2026-02-01 22:25:32
Check Details
Comparison of the three most popular brands of voclosporin and their efficacy and market evaluation
2026-02-01 22:25:32
Check Details
Clinical reference guide for drugs and next treatment options after ponatinib resistance
2026-02-01 22:25:32
Check Details
1
2
...
2318
2319
2320
2321
2322
2323
2324
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
2
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
3
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
4
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
5
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
6
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
7
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
8
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
9
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
10
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
11
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
12
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment